Thyrotropin Binding Inhibiting Antibody (TBIAb) in Graves’ Disease

To determine the nature of TBIAb in Graves’ disease, TBIAb was measured and correlated to various clinical, thyroid functional indices and thyroid autoantibodies. The incidence of TBIAb in untreated Graves’ patients, patients in treatment and those in remission was 70.9%, 53.1% and 19.2%, respective...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Korean J Intern Med
Egile Nagusiak: Cho, Won Yong, Choi, Hyang Hee, Chun, Hun Jae, Ahn, Il-Min
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Korean Association of Internal Medicine 1988
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4532134/
https://ncbi.nlm.nih.gov/pubmed/2908684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.1988.3.1.45
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak